{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:33:11Z","timestamp":1772998391583,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Internal Grant Agency, Ministry of Health, Czech Republic","award":["NT\/13412-4"],"award-info":[{"award-number":["NT\/13412-4"]}]},{"name":"University Hospital Hradec Kr\u00e1lov\u00e9","award":["00179906"],"award-info":[{"award-number":["00179906"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.thromres.2015.05.010","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T19:38:36Z","timestamp":1432150716000},"page":"1082-1086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Venous thromboembolism in patients with chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"136","author":[{"given":"M.","family":"\u0160imkovi\u010d","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vod\u00e1rek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moty\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Belada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vrback\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"\u017d\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Smolej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2015.05.010_bb0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.thromres.2011.11.034","article-title":"Hematologic malignancies and thrombosis","volume":"129","author":"Elice","year":"2012","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2015.05.010_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1470-2045(05)70207-2","article-title":"Cancer and venous thromboembolism","volume":"6","author":"Prandoni","year":"2005","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.thromres.2015.05.010_bb0015","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/ATVBAHA.108.177444","article-title":"Tissue factor and cancer stem cells: is there a linkage?","volume":"29","author":"Milsom","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.thromres.2015.05.010_bb0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/ATVBAHA.109.200964","article-title":"Tissue factor-bearing microparticles and thrombus formation","volume":"31","author":"Zwicker","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2015.05.010_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.thromres.2015.05.010_bb0030","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2015.05.010_bb0035","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2015.05.010_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10552-007-9097-2","article-title":"Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002","volume":"19","author":"Yamamoto","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.thromres.2015.05.010_bb0045","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network","volume":"105","author":"Smith","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.thromres.2015.05.010_bb0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2015.05.010_bb0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.leukres.2010.11.011","article-title":"Chronic lymphocytic leukaemia is a risk factor for venous thromboembolism","volume":"35","author":"Whittle","year":"2011","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.thromres.2015.05.010_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2011.09.022","article-title":"Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma","volume":"130","author":"Yokoyama","year":"2012","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2015.05.010_bb0065","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1016\/j.thromres.2012.03.019","article-title":"Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population","volume":"130","author":"Park","year":"2012","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2015.05.010_bb0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/10428190600560991","article-title":"Venous thromboembolism in patients with diffuse large B-cell lymphoma","volume":"47","author":"Komrokji","year":"2006","journal-title":"Leuk. Lymphoma"},{"issue":"10","key":"10.1016\/j.thromres.2015.05.010_bb0075","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.amjmed.2010.05.021","article-title":"Incidence and Risk Factors of Venous Thromboembolic Events in Lymphoma","volume":"123","author":"Zhou","year":"2010","journal-title":"Am. J. Med."},{"issue":"26","key":"10.1016\/j.thromres.2015.05.010_bb0080","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1182\/blood-2010-01-258624","article-title":"Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events","volume":"115","author":"Caruso","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2015.05.010_bb0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2015.05.010_bb0090","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1378\/chest.12-1446","article-title":"Use of Oral Glucocorticoids and the Risk of Pulmonary Embolism A Population-Based Case-Control Study","volume":"143","author":"Stuijver","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.thromres.2015.05.010_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0038-1656320","article-title":"Inhibition of Fibrinolytic-Activity in Vivo by Dexamethasone is Counterbalancedby an Inhibition of Platelet-Aggregation","volume":"68","author":"Vangiezen","year":"1992","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2015.05.010_bb0100","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1538-7836.2010.04034.x","article-title":"Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors","volume":"8","author":"Zaane","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2015.05.010_bb0105","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/1097-0142(19851215)56:12<2865::AID-CNCR2820561225>3.0.CO;2-6","article-title":"Chronic lymphocytic-leukemia with hyperleukocytosis - the hyperviscosity syndrome","volume":"56","author":"Baer","year":"1985","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.thromres.2015.05.010_bb0110","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/1042819021000006367","article-title":"Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral vein","volume":"43","author":"Cukierman","year":"2002","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.thromres.2015.05.010_bb0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1160\/TH08-04-0255","article-title":"Venous thromboembolism in the elderly. A community-based perspective","volume":"100","author":"Spencer","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"23 Suppl. 1","key":"10.1016\/j.thromres.2015.05.010_bb0120","first-page":"I9","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2015.05.010_bb0125","author":"National Cancer Institute"},{"issue":"3","key":"10.1016\/j.thromres.2015.05.010_bb0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jth.12480","article-title":"The contribution of immobility risk factors to the incidence of venous thrombosis in an older population","volume":"12","author":"Engbers","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.05.010_bb0135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-physiol-012110-142305","article-title":"Venous valvular stasis-associated hypoxia and thrombosis: what is the link?","volume":"73","author":"Bovill","year":"2011","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.thromres.2015.05.010_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-138-2-200301210-00014","article-title":"Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system","volume":"138","author":"Crowther","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2015.05.010_bb0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2007.69","article-title":"Patient outcomes after deep vein thrombosis and pulmonary embolism","volume":"168","author":"Spencer","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2015.05.010_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MOH.0b013e3283063a51","article-title":"Long-term outcome of pulmonary embolism","volume":"15","author":"Meyer","year":"2008","journal-title":"Curr. Opin. Hematol."},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2015.05.010_bb0160","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0049-3848(14)50004-7","article-title":"Lymphoma and venous thromboembolism: influence on mortality","volume":"133","author":"Mahajan","year":"2014","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2015.05.010_bb0165","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","article-title":"Recurrent venous thromboembolism after deep vein thrombosis - Incidence and risk factors","volume":"160","author":"Hansson","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"17","key":"10.1016\/j.thromres.2015.05.010_bb0170","doi-asserted-by":"crossref","first-page":"2189-U195","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"31","author":"Lyman","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2015.05.010_bb0175","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S0049-3848(10)70028-1","article-title":"Venous thromboembolism (VTE) in cancer patients. ESMO Clinical Recommendations for prevention and management","volume":"125","author":"Mandala","year":"2010","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2015.05.010_bb0180","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2015.05.010_bb0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2015.05.010_bb0195","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.2014.59.7351","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014","volume":"33","author":"Lyman","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.thromres.2015.05.010_bb0200","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1538-7836.2005.01467.x","article-title":"The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment","volume":"3","author":"De Stefano","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.05.010_bb0205","series-title":"Imbruvica (ibrutinib) [product monograph]","year":"2014"},{"issue":"2","key":"10.1016\/j.thromres.2015.05.010_bb0210","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6602945","article-title":"Increased risk of venous thromboembolism in patients with acute leukaemia","volume":"94","author":"Mohren","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"1-2","key":"10.1016\/j.thromres.2015.05.010_bb0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2004.07.016","article-title":"Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis","volume":"115","author":"Ziegler","year":"2005","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.thromres.2015.05.010_bb0220","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/sj.bjc.6602504","article-title":"Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis","volume":"92","author":"Mohren","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.thromres.2015.05.010_bb0225","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-0609.1995.tb00214.x","article-title":"Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance","volume":"54","author":"Ottinger","year":"1995","journal-title":"Eur. J. Haematol."},{"issue":"10","key":"10.1016\/j.thromres.2015.05.010_bb0230","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/annonc\/mdh385","article-title":"The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance","volume":"15","author":"Sallah","year":"2004","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.thromres.2015.05.010_bb0235","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2008-04-151076","article-title":"Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2015.05.010_bb0240","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/cncr.20405","article-title":"Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease","volume":"101","author":"Srkalovic","year":"2004","journal-title":"Cancer"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815002376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815002376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T06:20:19Z","timestamp":1566714019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384815002376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0049384815002376"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.05.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolism in patients with chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}